Ozempic Teeth: Semaglutide Dental Effects Explained

What Is "Ozempic Teeth"?

"Ozempic teeth" is a phrase that grew out of patient reports, social media threads, and observations from dental practices. It is not a clinical diagnosis and it does not appear in any FDA labeling. People use it loosely to describe a cluster of oral changes seen during semaglutide treatment: persistent dry mouth, enamel erosion, new cavities, gum irritation, and bad breath. Although the nickname centers on Ozempic, the same effects can show up across the broader GLP-1 class, including Wegovy and other agents.

It helps to be precise about the brands. Ozempic is semaglutide approved for type 2 diabetes at doses up to 2 mg weekly. Wegovy is the same molecule approved for weight management at a 2.4 mg maintenance dose (7.2 mg maximum). The higher-dose weight-management version produces more of the gastrointestinal side effects that drive dental risk, so where the rates differ, this guide names the specific product and dose rather than blending them.

The Three Mechanisms That Drive It

Almost everything filed under "Ozempic teeth" traces back to three indirect pathways, not to the drug damaging enamel directly. First, reduced saliva (dry mouth) removes the mouth's natural defense against acid and bacteria. Second, semaglutide slows how fast the stomach empties, which can worsen acid reflux and bathe the upper teeth in stomach acid. Third, nausea and vomiting bring gastric acid into direct contact with enamel. The next three sections walk through each one.

Mechanism 1: Dry Mouth (Xerostomia)

Saliva does more than keep your mouth comfortable. It buffers acid, washes away food debris, carries antimicrobial proteins, and supplies the calcium and phosphate that remineralize early enamel damage. When saliva drops, all of that protection drops with it, which is why dry mouth sits at the center of the "Ozempic teeth" picture.

One caveat matters here. Dry mouth is not listed as a labeled adverse reaction in the Wegovy or Ozempic prescribing information. What exists instead is a pharmacovigilance signal. A 2025 narrative review by Barać and Roganović analyzed the FDA Adverse Event Reporting System and found that semaglutide carried the strongest dry mouth signal of the GLP-1 drugs they examined, with a reporting odds ratio of 3.21 and a proportional reporting ratio of 3.19. A signal of this kind flags a pattern worth watching; it is not the same as a confirmed, rate-quantified side effect from a randomized trial.

On the clinical side, a 2023 case series in the journal Medicine by Mawardi and colleagues documented three patients who developed severe hyposalivation while taking semaglutide for weight loss, appearing after a mean of about 11 weeks of use. Three cases is a small number, and case series cannot establish how common a problem is, but it is among the first published clinical descriptions of the effect.

Mechanism 2: Acid Reflux (GERD) and Enamel Erosion

One of semaglutide's core actions is slowing gastric emptying, the rate at which food leaves your stomach. That effect helps with appetite control and blood sugar, but it can also worsen or trigger gastroesophageal reflux disease (GERD). When stomach contents linger and back up into the esophagus, some of that acid can reach the mouth and coat the teeth.

GERD is a labeled effect at the weight-management dose. The Wegovy prescribing information reports gastroesophageal reflux disease in 5% of patients on the 2.4 mg dose, compared with 3% on placebo. Stomach acid sits at roughly pH 2, acidic enough to dissolve the mineral surface of enamel with repeated exposure. A 2026 dental management review in the Canadian Journal of Diabetes by Kofman and Ouanounou identifies enamel erosion from acid exposure, along with xerostomia, halitosis, and altered taste, as oral manifestations that clinicians should watch for in semaglutide patients.

How Gastric Emptying Connects to Dental Risk

The chain is short and mechanical. Delayed gastric emptying means food and acid stay in the stomach longer. A fuller stomach for longer raises the chance of reflux episodes, and each reflux episode that reaches the mouth bathes the upper back teeth in acid. Over months, that repeated acid contact can thin enamel on the surfaces it touches. If reflux symptoms appear or worsen after starting semaglutide, that is worth reporting to your prescriber, because managing the reflux also protects your teeth.

Mechanism 3: Vomiting-Related Acid Exposure

Nausea and vomiting are the most common gastrointestinal effects of semaglutide, and vomiting is the most direct enamel-erosion pathway of the three. Each episode brings stomach acid into contact with the teeth, the same mechanism that drives the enamel erosion seen in chronic acid reflux and in eating disorders such as bulimia.

The rates depend heavily on the product and dose, which is why it matters to keep them separate. At the lower Ozempic diabetes doses, vomiting affects roughly 5% to 9% of users and nausea about 15% to 20%. At the Wegovy 2.4 mg weight-management dose, the figures are much higher: the prescribing information reports vomiting in 24% of patients versus 6% on placebo, and nausea in 44%. The Wegovy label also notes that most nausea and vomiting reports occurred during dose escalation, which makes the titration phase the window of highest dental risk.

Is "Ozempic Teeth" an Official Side Effect?

No. Dry mouth, xerostomia, and dental damage are not listed as adverse reactions in the Wegovy or Ozempic FDA prescribing information. What is labeled are the gastrointestinal effects that create the secondary dental risk: nausea, vomiting, diarrhea, constipation, and, at the weight-management dose, GERD. In other words, the drivers are official; the dental consequence is a downstream effect that the label does not name.

The evidence that does exist is observational. The FDA adverse event reporting signal points to an emerging pattern, the 2023 case series describes real patients, and the 2026 dental review by Kofman and Ouanounou treats enamel erosion and xerostomia as recognized oral manifestations of semaglutide use. None of that is the same as a randomized controlled trial proving cause and effect, so the honest framing is that the association is biologically plausible and clinically observed, but not yet quantified for cavities or enamel erosion. There is no reliable percentage for how often "Ozempic teeth" occurs, and you should be skeptical of any source that gives you one.

How to Protect Your Teeth While on Semaglutide

Because the dental risk is indirect, most of it is manageable. The goal is to keep saliva up, reduce acid exposure, and catch problems early. None of this replaces your dentist's judgment, but these are the steps clinicians most often recommend.

Hydration and Saliva Stimulation

• Sip water throughout the day. Appetite suppression cuts how much you eat and drink, so dry mouth often tracks with low fluid intake. Steady sipping helps more than a few large drinks.
• Use sugar-free gum or lozenges. Xylitol-based products stimulate saliva flow and do not feed cavity-causing bacteria.
• Go easy on caffeine and alcohol. Both are drying, and alcohol-based mouthwashes can make xerostomia worse.

Dental Hygiene Adjustments

• Brush twice daily with fluoride toothpaste. Fluoride supports remineralization, which matters more when saliva is doing less of that job.
• Rinse after acid exposure, brush later. After vomiting or a reflux episode, rinse with water and wait about 30 minutes before brushing to avoid abrading softened enamel.
• Floss daily. Less saliva means less natural clearance of bacteria between teeth.
• Consider an alcohol-free fluoride mouthwash. It adds fluoride contact without the drying effect of alcohol formulas.

Work With Your Dentist and Prescriber

• Tell your dentist you take semaglutide. It changes how they read dry mouth, enamel changes, or erosion patterns.
• Ask about more frequent check-ups during active dose escalation, such as every 3 to 4 months, when GI side effects peak.
• Report new dry mouth, tooth sensitivity, or reflux to your prescribing provider. If GERD worsens noticeably, discussing acid suppression with your doctor can protect both your esophagus and your teeth.